NASDAQ:APMD Apnimed Q2 2026 Earnings Report $28.79 +1.34 (+4.88%) As of 04:00 PM Eastern ProfileEarnings HistoryForecast Apnimed EPS ResultsActual EPS$0.51Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AApnimed Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AApnimed Announcement DetailsQuarterQ2 2026Date9/8/2026TimeAfter Market ClosesConference Call DateTuesday, September 8, 2026Conference Call Time7:00AM ETConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Apnimed Earnings HeadlinesApnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update2 hours ago | globenewswire.comApnimed IncSeptember 5 at 7:55 PM | markets.ft.comThis sub-5 dollar stock operates next to SpaceX and Blue OriginA small public company trading under $5 a share operates inside the secure perimeter of Kennedy Space Center, right alongside SpaceX and Blue Origin. It holds a special agreement to use a multi-billion dollar federal launch facility for just $500, and its customer list already includes the Pentagon, Lockheed Martin, and GE Aerospace. Most Wall Street analysts have not caught on yet, but a major milestone could change that soon.September 8 at 1:00 AM | Freedom Financial (Ad)Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)September 4, 2026 | globenewswire.comBrokerages Set Apnimed, Inc. (NASDAQ:APMD) PT at $50.33September 2, 2026 | americanbankingnews.comBofA makes bullish call on newly public biotech stock ApnimedAugust 29, 2026 | msn.comSee More Apnimed Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Apnimed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Apnimed and other key companies, straight to your email. Email Address About ApnimedApnimed (NASDAQ:APMD) Inc. is a late stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies which address the neurobiology of sleep-related breathing diseases. Apnimed Inc. is based in CAMBRIDGE, Mass.View Apnimed ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom StockCampbell’s Dividend Cut May Reset the Stock, But the Turnaround Still Has to DeliverQ3 Earnings Could Be the Catalyst the Market Has Been Waiting For3 AI Optical Networking Stocks Positioned for the Data Center BuildoutSafety Stocks Are Not What They Used to Be: 4 Names Built for a Weaker DollarMarketBeat Week in Review – 08/31 - 09/04Why Guidewire’s Post-Earnings Plunge May Not Last Upcoming Earnings Adobe (9/10/2026)Oracle (9/10/2026)Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/8/2026)America Movil (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
